Keyphrases
Racial Disparities
100%
Allergic Rhinitis
100%
Sublingual Immunotherapy
100%
Patient Relatives
57%
Relative Risk
42%
Confidence Interval
42%
Non-Hispanic White
42%
White Patients
42%
Black Men
28%
Hispanic Patients
28%
United States
14%
Ethnic Differences
14%
Racial Groups
14%
Ethnic Groups
14%
Collaborative Networks
14%
Beta-blockers
14%
Observation Period
14%
Angiotensin-converting Enzyme Inhibitor (ACEi)
14%
Racial Differences
14%
Non-Hispanic
14%
Heart Disease
14%
Racial Identification
14%
Asian Patients
14%
Atopic Disease
14%
State Differences
14%
Ethnic Identification
14%
TriNetX
14%
Barriers to Treatment
14%
Age Standard
14%
Matched Cohort Study
14%
Electronic Health
14%
Prescription Practices
14%
Medicine and Dentistry
Desensitization
100%
Ethnic Disparity
100%
Racial Disparity
100%
Allergic Rhinitis
100%
Cohort Analysis
14%
Cardiovascular Disease
14%
Ethnic Group
14%
Racial Group
14%
ACE Inhibitor
14%
Race Difference
14%
Atopy
14%
Pharmacology, Toxicology and Pharmaceutical Science
Allergen
100%
Immunotherapy
100%
Allergic Rhinitis
100%
Cohort Study
14%
Dipeptidyl Carboxypeptidase Inhibitor
14%
Atopy
14%